These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 20594986)

  • 41. [Frequency of oral candidiasis in stem cell transplant patients].
    Hermann P; Berek Z; Kriván G; Márton K; Fejérdy P; Lengyel A
    Fogorv Sz; 2006 Feb; 99(1):9-14. PubMed ID: 16607934
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antifungal therapy in oropharyngeal mycotic infections.
    Epstein JB
    Oral Surg Oral Med Oral Pathol; 1990 Jan; 69(1):32-41. PubMed ID: 2404226
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunosuppression level in HIV-positive patients with oropharyngeal candidiasis.
    Arora U; Jagdev M; Jindal N
    Indian J Med Microbiol; 2009; 27(2):174-5. PubMed ID: 19384052
    [No Abstract]   [Full Text] [Related]  

  • 44. [Successful treatment of oro-pharyngo-oesophageal Candida albicans infection after renal transplantation (author's transl)].
    Zazgornik J; Kaiser R; Kopsa H; Schmidt P; Pötzi ; Hruby K
    Mykosen; 1978 Feb; 21(2):33-8. PubMed ID: 345119
    [No Abstract]   [Full Text] [Related]  

  • 45. Oral candidiasis in HIV-infected patients.
    Brawner DL; Hovan AJ
    Curr Top Med Mycol; 1995; 6():113-25. PubMed ID: 8724244
    [No Abstract]   [Full Text] [Related]  

  • 46. Oropharyngeal candidiasis in head and neck cancer patients treated with radiation: update 2011.
    Bensadoun RJ; Patton LL; Lalla RV; Epstein JB
    Support Care Cancer; 2011 Jun; 19(6):737-44. PubMed ID: 21479787
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Candida glabrata is an emerging cause of oropharyngeal candidiasis in patients receiving radiation for head and neck cancer.
    Redding SW; Dahiya MC; Kirkpatrick WR; Coco BJ; Patterson TF; Fothergill AW; Rinaldi MG; Thomas CR
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Jan; 97(1):47-52. PubMed ID: 14716255
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prophylaxis of oropharyngeal candidiasis with clotrimazole.
    Yeo E; Alvarado T; Fainstein V; Bodey GP
    J Clin Oncol; 1985 Dec; 3(12):1668-71. PubMed ID: 4067613
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immune defence mechanisms and immunoenhancement strategies in oropharyngeal candidiasis.
    Villar CC; Dongari-Bagtzoglou A
    Expert Rev Mol Med; 2008 Oct; 10():e29. PubMed ID: 18847522
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Effectiveness of antifungal agents for oral candidiasis in inpatients].
    Ohno T; Morita T; Ohta Y
    Gan To Kagaku Ryoho; 2012 Aug; 39(8):1233-8. PubMed ID: 22902448
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Perillaldehyde: A promising antifungal agent to treat oropharyngeal candidiasis.
    Chen L; Qu S; Yang K; Liu M; Li YX; Keller NP; Zeng X; Tian J
    Biochem Pharmacol; 2020 Oct; 180():114201. PubMed ID: 32822688
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oropharyngeal candidiasis in the era of antiretroviral therapy.
    Thompson GR; Patel PK; Kirkpatrick WR; Westbrook SD; Berg D; Erlandsen J; Redding SW; Patterson TF
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Apr; 109(4):488-95. PubMed ID: 20156694
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment strategies for oropharyngeal candidiasis.
    Laudenbach JM; Epstein JB
    Expert Opin Pharmacother; 2009 Jun; 10(9):1413-21. PubMed ID: 19505211
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of oropharyngeal candidiasis and candidal diaper dermatitis in neonates and infants: review and reappraisal.
    Hoppe JE
    Pediatr Infect Dis J; 1997 Sep; 16(9):885-94. PubMed ID: 9306485
    [No Abstract]   [Full Text] [Related]  

  • 55. Treatment for oropharyngeal candidiasis.
    Fasciana GS
    J Am Dent Assoc; 1984 Mar; 108(3):300, 302. PubMed ID: 6585401
    [No Abstract]   [Full Text] [Related]  

  • 56. [Local administration of amphotericin B (fungizone syrup) in oral candidiasis].
    Shinohara M; Nakamura S; Watanabe T
    Shikai Tenbo; 1985 Feb; 65(2):425-36. PubMed ID: 3857714
    [No Abstract]   [Full Text] [Related]  

  • 57. Candida pyelonephritis and candiduria: the clinical significance of candida albicans in urine cultures.
    Seneca H; Longo F; Peer P
    J Urol; 1968 Sep; 100(3):266-9. PubMed ID: 5677044
    [No Abstract]   [Full Text] [Related]  

  • 58. Oral and pharyngeal candidiasis. Topical agents for management and prevention.
    Epstein JB
    Postgrad Med; 1989 Apr; 85(5):257-8, 263-5, 268-9. PubMed ID: 2648372
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A preliminary study of suppression of candida infection by miconazole mucoadhesive tablets in oral or oropharyngeal cancer patients undergoing radiotherapy.
    Soutome S; Otsuru M; Kawashita Y; Yoshimatsu M; Funahara M; Murata M; Ukai T; Umeda M; Saito T
    Sci Rep; 2022 Jun; 12(1):10188. PubMed ID: 35715518
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Oral candidiasis: epidemiology, diagnosis and treatment].
    Samson J
    Schweiz Monatsschr Zahnmed; 1990; 100(5):548-59. PubMed ID: 2194282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.